Literature DB >> 5285381

Interactions between digitoxin and other drugs in vitro and in vivo.

H M Solomon, S Reich, N Spirt, W B Abrams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5285381     DOI： 10.1111/j.1749-6632.1971.tb46913.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  15 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  [The effect of probenecid on the distribution of digitoxin, digoxin and ouabain in the mouse].

Authors:  K H Damm; W Braun; H Heckert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  [The effect of some drugs on the protein binding of phenol red and digitoxin].

Authors:  R Beeck; W Braun; K H Damm; R Erttmann; T Gerhardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 5.  Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.

Authors:  H Kutt; S Louis
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 6.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 7.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.

Authors:  K Morita; H Shibata; T Ono; H Shimakawa
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.